Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan for Acute Cough in Pediatric Population
NCT02651116Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Feb 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cough comparing Dextromethorphan Hydrobromide with Placebo (2 arms). Primary endpoint: Mean of Total Cough Counts Over 24 Hours Post-First Dose. Started Feb 2016; status: terminated.
02
Drugs
dextromethorphan
03
Conditions
cough
Beyond the preview
Go deeper on NCT02651116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651116.